Krauz L - Search Results

1

Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease.

Saraf S, Farooqui M, Infusino G, Oza B, Sidhwani S, Gowhari M, Vara S, Gao W, Krauz L, Lavelle D, DeSimone J, Molokie R, Saunthararajah Y. Saraf S, et al. Among authors: krauz l. Br J Haematol. 2011 May;153(3):386-92. doi: 10.1111/j.1365-2141.2010.08479.x. Epub 2011 Mar 21. Br J Haematol. 2011. PMID: 21418176 Free article.

2

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Molokie R, Lavelle D, Gowhari M, Pacini M, Krauz L, Hassan J, Ibanez V, Ruiz MA, Ng KP, Woost P, Radivoyevitch T, Pacelli D, Fada S, Rump M, Hsieh M, Tisdale JF, Jacobberger J, Phelps M, Engel JD, Saraf S, Hsu LL, Gordeuk V, DeSimone J, Saunthararajah Y. Molokie R, et al. Among authors: krauz l. PLoS Med. 2017 Sep 7;14(9):e1002382. doi: 10.1371/journal.pmed.1002382. eCollection 2017 Sep. PLoS Med. 2017. PMID: 28880867 Free PMC article. Clinical Trial.

3

Inpatient management of sickle cell pain: a 'snapshot' of current practice.

Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Miller ST, et al. Am J Hematol. 2012 Mar;87(3):333-6. doi: 10.1002/ajh.22265. Epub 2012 Jan 9. Am J Hematol. 2012. PMID: 22231150 Free PMC article.

4

Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial.

Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP; Sickle Cell Disease Clinical Research Network (SCDCRN). Peters-Lawrence MH, et al. Contemp Clin Trials. 2012 Mar;33(2):291-7. doi: 10.1016/j.cct.2011.11.018. Epub 2011 Dec 2. Contemp Clin Trials. 2012. PMID: 22155024 Free PMC article. Clinical Trial.

5

Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making.

Jani AB, Blend MJ, Hamilton R, Brendler C, Pelizzari C, Krauz L, Vijayakumar S, Sapra B, Awan A, Weichselbaum RR. Jani AB, et al. Among authors: krauz l. J Nucl Med. 2004 Apr;45(4):571-8. J Nucl Med. 2004. PMID: 15073252 Free article. Clinical Trial.

6

Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy.

Jani AB, Spelbring D, Hamilton R, Blend MJ, Pelizzari C, Brendler C, Krauz L, Vijayakumar S, Sapra B, Weichselbaum RR. Jani AB, et al. Among authors: krauz l. J Nucl Med. 2004 Feb;45(2):238-46. J Nucl Med. 2004. PMID: 14960642 Free article.

7

Analysis of prostate-specific antigen rebound interval in patients with prostate cancer receiving hormonal therapy and external-beam radiation therapy.

Jani AB, Al-Qamari A, Sapra B, Krauz L, Awan A, Kocherginsky M, Gillen D. Jani AB, et al. Among authors: krauz l. Clin Prostate Cancer. 2004 Jun;3(1):43-8. doi: 10.3816/cgc.2004.n.012. Clin Prostate Cancer. 2004. PMID: 15279690

8

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis.

Jani AB, Hand CM, Pelizzari CA, Roeske JC, Krauz L, Vijayakumar S. Jani AB, et al. Among authors: krauz l. BMC Cancer. 2003 May 13;3:16. doi: 10.1186/1471-2407-3-16. BMC Cancer. 2003. PMID: 12744725 Free PMC article.

9

Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.

Jani AB, Blend MJ, Hamilton R, Brendler C, Pelizzari C, Krauz L, Sapra B, Vijayakumar S, Awan A, Weichselbaum RR. Jani AB, et al. Among authors: krauz l. J Nucl Med. 2004 Aug;45(8):1315-22. J Nucl Med. 2004. PMID: 15299055 Free article.

10

Impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate-, or high-risk prostate cancer.

Jani AB, Basu A, Abdalla I, Connell PP, Krauz L, Vijayakumar S. Jani AB, et al. Among authors: krauz l. Am J Clin Oncol. 2003 Aug;26(4):382-5. doi: 10.1097/01.COC.0000026483.80660.94. Am J Clin Oncol. 2003. PMID: 12902891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page